| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |